$4.90
-0.02-0.42%
At Close: -
$5.10
0.24.08%
After Hours: 8:04 AM EDT
15 minutes delayed
Intensity Therapeutics
INTSNASDAQ
Intensity Therapeutics (INTS) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestIntensity Therapeutics (NASDAQ:INTS) Stock Quotes, Forecast and News Summary
Intensity Therapeutics Stock (NASDAQ: INTS) stock price, news, charts, stock research, profile.
| Open | $4.92 |
| Close | $4.90 |
| Volume / Avg. | 7.42K / 15.83K |
| Day Range | 4.90 - 5.00 |
| 52 Wk Range | 2.01 - 11.44 |
| Market Cap | $67.19M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 54 |
| Short Interest | 0.36% |
| Days to Cover | 3.29 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Intensity Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based a...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Intensity Therapeutics (INTS) stock?
You can purchase shares of Intensity Therapeutics (NASDAQ:INTS) through any online brokerage.
Who are Intensity Therapeutics (INTS) competitors?
Other companies in Intensity Therapeutics’s space includes: Serina Therapeutics (AMEX:SER), HOOKIPA Pharma (NASDAQ:HOOK), Connect Biopharma Hldgs (NASDAQ:CNTB), Burning Rock Biotech (NASDAQ:BNR) and Eagle Pharmaceuticals (NASDAQ:EGRX).
What is the target price for Intensity Therapeutics (INTS) stock?
There is no analysis for Intensity Therapeutics.
What is the forecast for Intensity Therapeutics (INTS) stock?
Intensity Therapeutics has a consensus price target of $12.00.
Current stock price for Intensity Therapeutics (INTS)?
The stock price for Intensity Therapeutics (NASDAQ: INTS) is $5.1 last updated June 26, 2024 at 8:04 AM EDT.
Does Intensity Therapeutics (INTS) pay a dividend?
There are no upcoming dividends for Intensity Therapeutics.
When is Intensity Therapeutics (NASDAQ:INTS) reporting earnings?
Intensity Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
Is Intensity Therapeutics (INTS) going to split?
There is no upcoming split for Intensity Therapeutics.
What sector and industry does Intensity Therapeutics (INTS) operate in?
Intensity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.